You can certainly get this device into a backpack and carry it from point A to point B.
Jokes aside. I think this is a good thing, if you evaluate the matter holistically. This certainly signals that there is demand and a market for diabetic retinopathy screening. Now Opto just needs to build deep roots within healthcare systems so that switching won’t be so easy anymore, provided that a new compact camera eventually enters the market.